Form 4 holding
CEO and President, Director
RECURSION PHARMACEUTICALS, INC.
- Security class
- Class A Common Stock
- Shares / value
- 2,175,796
- Estimated value
- $7,790,655
- Report date
- 05 Jun 2026
- Price
- $3.58
- Ownership
- Direct